Dasiglucagon
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Dasiglucagon
- Accession Number
- DB15226
- Description
Dasiglucagon is under investigation in clinical trial NCT03735225 (Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration).
- Type
- Biotech
- Groups
- Investigational
- Synonyms
- Dasiglucagon
Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:Accelerate your drug discovery research with our fully connected ADMET dataset- Indication
- Not Available
- Contraindications & Blackbox Warnings
Contraindications & Blackbox WarningsWith our commercial data, access important information on dangerous risks, contraindications, and adverse effects.Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Reduce medical errorsand improve treatment outcomes with our comprehensive & structured data on drug adverse effects.Reduce medical errors & improve treatment outcomes with our adverse effects data- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Comprehensive & structured drug product infoFrom application numbers to product codes, connect different identifiers through our commercial datasets.Easily connect various identifiers back to our datasets- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Zegalogue Injection, solution 0.6 mg/0.6mL Subcutaneous Zealand Pharma A/S 2021-04-05 Not applicable US 
Zegalogue Injection, solution 0.6 mg/0.6mL Subcutaneous Zealand Pharma A/S 2021-04-05 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
Chemical Identifiers
- UNII
- AD4J2O47FQ
- CAS number
- 1544300-84-6
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Completed Treatment Congenital Hyperinsulinism 1 3 Completed Treatment Hypoglycemia 1 3 Completed Treatment Hypoglycemia / Type 1 Diabetes Mellitus 4 3 Enrolling by Invitation Treatment Congenital Hyperinsulinism 1 2 Completed Treatment Hyperinsulinemic Hypoglycemia / Postprandial Hypoglycemia 1 2 Completed Treatment Hypoglycemia / Type 1 Diabetes Mellitus 1 2 Completed Treatment Type 1 Diabetes Mellitus 2 2 Not Yet Recruiting Treatment Hypoglycemia / Type 1 Diabetes Mellitus 1 2, 3 Completed Treatment Type 1 Diabetes Mellitus 1 2, 3 Recruiting Treatment Congenital Hyperinsulinism 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Subcutaneous 0.6 mg/0.6mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on May 20, 2019 15:01 / Updated on February 21, 2021 18:55